Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?

  title={Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal?},
  author={Pearl Ihuoma Akazue and Godwin U. Ebiloma and O. Ajibola and C. Isaac and K. Onyekwelu and Charles Ezeh and A. Eze},
The recent massive reduction in the numbers of fresh Human African Trypanosomiasis (HAT) infection has presented an opportunity for the global elimination of this disease. To prevent a possible resurgence, as was the case after the reduced transmission of the 1960s, surveillance needs to be sustained and the necessary tools for detection and treatment of cases need to be made available at the points of care. In this review, we examine the available resources and make recommendations for… Expand
Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences
Analyzing the perspectives and experiences of frontline nurses, technicians, and coordinators who work for the HAT programme in the former province of Bandundu in the Democratic Republic of the Congo suggests concrete pathways for improving the effectiveness of elimination efforts. Expand
Epizootiology and Molecular Identification of Trypanosome Species in Livestock Ruminants in the Gambia.
The incidence of nagana in The Gambia is documented and the prevalent trypanosomes identified to be T. congolense as the most predominanttrypanosome species infecting animals in the Gambia. Expand
Loop-Mediated Isothermal Amplification as Point-of-Care Diagnosis for Neglected Parasitic Infections
This review describes the advances made to date regarding LAMP tests, as it has been found that even though several studies have been conducted concerning most NPI, information is scarce for others. Expand
Antischistosomal, antionchocercal and antitrypanosomal potentials of some Ghanaian traditional medicines and their constituents
Traditional medicines used for treating various NTDs in local communities were screened in vitro for efficacy against schistosomiasis, onchocerciasis and African trypanosOMiasis and justify the use of traditional medicines and demonstrate their prospects towards NTD drugs discovery. Expand
Comprehensive analysis of oral administration of Vitamin E on the early stage of Trypanosoma brucei brucei infection
The treatment was able to ameliorate the anaemia and organ damage caused by Trypanosoma Brucei brucei , extend the life span of the treated rats and greatly delay the time taken to get to the second stage of the infection. Expand
Effect of zebra skin-derived compounds on field catches of the human African trypanosomiasis vector Glossina fuscipes fuscipes.
It is concluded that geranyl acetone accounts for the repellent effect of blend K on the riverine tsetse fly, G. f. Expand
Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
The aim of this study was to develop a method for isolation of d- and l-eflornithine from a racemic mixture to support and assess the feasibility of a future clinical program with an oral HAT treatment. Expand
Antiparasitic and Cytotoxic Activity of Bokkosin, A Novel Diterpene-Substituted Chromanyl Benzoquinone From Calliandra portoricensis
The identification of bokkosin constitutes the first isolation of this class of compound from any natural source and establishes the compound as a potential trypanocide that, considering its novelty, should now be tested for activity against other microorganisms as well. Expand
Synthesis and In Vitro Antiprotozoan Evaluation of 4-/8-Aminoquinoline-based Lactams and Tetrazoles
A second generation of 4-aminoquinoline- and 8-amzinoline-based tetrazoles and lactams were synthesized via the Staudinger and Ugi multicomponent reactions and displayed good antiplasmodium activities and antitrypanosomal activity that were comparable to the reference drugs. Expand


Human African Trypanosomiasis Presenting at Least 29 Years after Infection—What Can This Teach Us about the Pathogenesis and Control of This Neglected Tropical Disease?
A unique case of a patient harbouring the parasite for more than three decades before developing stage 2 sleeping sickness is presented. Expand
Crisis, what crisis? Control of Rhodesian sleeping sickness.
There is an urgent need for cost-effective strategies for the sustainable control of Trypanosoma brucei rhodesiense (Rhodesian) sleeping sickness, which is a fatal zoonotic disease that has causedExpand
Monitoring the elimination of human African trypanosomiasis: Update to 2016
Elimination of HAT as a public health problem by 2020 seems within reach, as the epidemiological trends observed in previous years are confirmed in this latest 2016 monitoring update, and an overall improvement in the coverage of at risk populations by surveillance activities was observed. Expand
[Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies].
Results of active and passive surveillance indicate that all sleeping sickness patients diagnosed these last years in Burkina Faso were imported cases from Côte d'Ivoire, and the re-introduction of the parasite is effective and the risk of a resumption of transmission exists. Expand
Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
A situational update to 2012 is provided for a number of indicators of elimination: number of cases annually reported, geographic distribution of the disease and areas and populations at different levels of risk, and trends in the selected indicators suggest that, in recent years, progress has been steady and in line with the elimination goal. Expand
The Long Wait for a New Drug for Human African Trypanosomiasis.
The limitations of current chemotherapeutic approaches to manage HAT are examined, the constraints to new drug development exploring drug failures and new drugs on the horizon are considered, and the epidemiological, political, social, and economic factors influencing drug development are considered. Expand
Control and surveillance of human African trypanosomiasis.
  • Medicine
  • World Health Organization technical report series
  • 2013
Information about new diagnostic approaches, new therapeutic regimens and better understanding of the distribution of the disease with high-quality mapping are provided, forming the basis for an integrated strategy with which it is hoped that elimination of gambiense HAT will be achieved. Expand
Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination.
Although the prevalence of HAT is decreasing and its elimination is targeted, control approaches must be adapted to the different epidemiological patterns in order to adopt the most adequate strategies to maintain their cost-effectiveness. Expand
Monitoring the elimination of human African trypanosomiasis: Update to 2014
HAT elimination appears to be on track, and the 2020 global target of ‘fewer than 2,000 reported cases per year’ seems within reach. Expand
Challenges facing the elimination of sleeping sickness in west and central Africa: sustainable control of animal trypanosomiasis as an indispensable approach to achieve the goal
The training of inhabitants on how to implement and sustain vector control tools will enable a long-term sustainability of control operations that will lead to the elimination of HAT and AAT. Expand